Wits Health Research Funding Boost Targets Immediate Gaps
Wits Health Research Funding receives a R7m boost from the Oppenheimer Memorial Trust to support those affected by US funding cuts.
Wits Health Research Funding receives a R7m boost from the Oppenheimer Memorial Trust to support those affected by US funding cuts.
Botswana Medicine Shortages are worsening as procurement delays, weak supply chains, and poor data systems leave clinics without drugs.
Roche CT-388 Obesity Drug shows up to 22.5% placebo-adjusted weight loss at 48 weeks, as Roche moves into Phase 3 to challenge Lilly and Novo.
AI in Drug Development is cutting trial setup and regulatory paperwork, with Novartis and GSK citing major time and cost savings.
South Africa faces an HIV ARV tender crisis as major suppliers enter business rescue, risking vital medicine availability.